On the RAC side, the GA and SFN are widely studied molecules with neuroprotective effects, as their use is reported for the treatment of free radical‐induced disorders of the nervous system [60, 61], since redox‐regulating molecules are typically involved in the defense system against ROS. This evidence concerns the gene SFN and nervous system disorder.